NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem

Filippos Kottakis1, Parthena Foltopoulou1, Ioannis Sanidas1

  • 1Authors' Affiliation: Molecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts.

Cancer Research
|May 24, 2014
PubMed

Insights

The histone demethylase NDY1/KDM2B promotes cancer growth and stem cell self-renewal. Inhibiting NDY1 halts tumor growth by affecting cell cycle progression and differentiation, offering a potential therapeutic target.

Area of Science:

  • Epigenetics and Cancer Biology
  • Stem Cell Biology
  • Gene Regulation

Background:

  • The JmjC domain histone demethylase NDY1/KDM2B is frequently overexpressed in diverse human cancers.
  • NDY1/KDM2B plays a role in regulating gene expression through histone modification.

Purpose of the Study:

  • To investigate the role of NDY1/KDM2B in cancer cell proliferation, self-renewal, and differentiation.
  • To elucidate the molecular mechanisms by which NDY1/KDM2B influences cancer stem cell properties.

Main Methods:

  • Knockdown of NDY1 in various human cancer cell lines.
  • Assessment of anchorage-dependent and independent growth, senescence, apoptosis, and cell cycle progression.
  • Analysis of mammosphere formation and stem cell marker expression (ALDH, CD44, CD24).
  • Orthotopic injection of modified tumor cells in animal models.
  • Investigation of miRNA regulation and polycomb complex targeting.
  • Correlation analysis of NDY1/KDM2B, miRNA, and polycomb target expression in human breast cancer tissues.

Main Results:

  • NDY1 knockdown inhibited cancer cell growth, induced senescence/apoptosis, and blocked G1 progression across multiple tumor types.
  • NDY1 inhibition reduced mammosphere formation and altered stem cell marker expression, suggesting impaired cancer stem cell self-renewal.
  • NDY1 knockdown led to miRNA de-repression, targeting polycomb complexes (PRC1/PRC2), and promoted tumor cell differentiation.
  • Overexpression of NDY1/KDM2B in triple-negative breast cancer correlated with relapse rates, and its expression inversely correlated with NDY1-regulated miRNAs in primary tumors.

Conclusions:

  • NDY1/KDM2B is essential for cancer stem cell self-renewal and tumor growth.
  • NDY1 acts as a master regulator of miRNAs targeting polycomb complexes, influencing cancer cell plasticity.
  • Targeting NDY1/KDM2B represents a potential therapeutic strategy for cancers, particularly triple-negative breast cancer.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K